Clinical Trial Update: A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of NeoRecormon (epoetin beta) in patients with end-stage renal disease, focusing on anemia management; the study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED